• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Lillys Bad Bet

Anonymous

Guest
Lilly doubled down on beta amyloid researchers found it to be tau not beta amyloid. The good Dr. Lechlieter is not a good businessman or scientist, but he's a great opportunist, huge bank account for outstanding performance.